These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5128423)

  • 41. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
    Rottini E; Martinelli M; Capitanucci P; De Gregorio M
    Boll Soc Ital Biol Sper; 1967 Aug; 43(16):970-2. PubMed ID: 6073457
    [No Abstract]   [Full Text] [Related]  

  • 42. [Endogenous intoxication syndrome in patients in late stages of obliterating atherosclerosis in vessels of lower extremities].
    Dubikaĭtis AIu; Belotserkovskiĭ MV; Koniukhova SG; Strashnov VI
    Biull Eksp Biol Med; 1993 Feb; 115(2):148-51. PubMed ID: 8043789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of a new sympatholytic drug in therapy of chronic peripheral obliterating artery diseases].
    Vittori C; Taborelli G; Taborelli R
    Minerva Cardioangiol; 1965 Sep; 13(9):585-91. PubMed ID: 5851172
    [No Abstract]   [Full Text] [Related]  

  • 44. [A method of insulin therapy of chronic obliterating arteriopathies. Clinical results and etiopathogenetic considerations].
    Bonessa C; Cremonini L
    Minerva Med; 1966 Jul; 57(44):2027-40. PubMed ID: 5942708
    [No Abstract]   [Full Text] [Related]  

  • 45. [Differentiated medical gymnastics in some obliterating diseases of the lower extremities].
    Sevast'ianova AS
    Zh Eksp Klin Med; 1970 Jun; 10(6):102-7. PubMed ID: 5520560
    [No Abstract]   [Full Text] [Related]  

  • 46. [Problems in the use of anticoagulants in severe arterial occlusive diseases of the limbs].
    Linke H
    Z Gesamte Inn Med; 1970 Aug; 25(15):688-93. PubMed ID: 5527533
    [No Abstract]   [Full Text] [Related]  

  • 47. [The use of regional artificial circulation in the treatment of obliterating thrombosis of the lower limbs].
    Dutkevich IG; Farshatov MN; Glebov IuI; Dekster BG
    Vestn Khir Im I I Grek; 1966 Jun; 96(6):122-6. PubMed ID: 6000568
    [No Abstract]   [Full Text] [Related]  

  • 48. [Efficacy of a new pentoxifilline form-vasonit retard in the treatment of patients with obliterating diseases of the lower limbs arteries].
    Koshkin VM
    Ter Arkh; 2005; 77(4):83-4. PubMed ID: 15938541
    [No Abstract]   [Full Text] [Related]  

  • 49. [Obliterating arteriosclerosis of the lower extremities. Cause of death noted by follow-up studies].
    Martorell F; Martorell A
    Angiologia; 1967; 19(1):38-42. PubMed ID: 5598416
    [No Abstract]   [Full Text] [Related]  

  • 50. [Late results of treatment of circulatory disorders of the lower extremities with Mydocalm].
    Chmielewski F
    Wiad Lek; 1969 Mar; 22(6):575-80. PubMed ID: 5788875
    [No Abstract]   [Full Text] [Related]  

  • 51. [Angiocardiographic findings in patients with obliterating changes in the arteries of the extremities and with normal resting EKG].
    Schoop W; Kiefer H; Blümchen G
    Z Kreislaufforsch; 1966 Sep; 55(9):884-90. PubMed ID: 5998954
    [No Abstract]   [Full Text] [Related]  

  • 52. [Intra-arterial infusions of solcoseryl in the treatment of obliterative diseases of the peripheral arteries in the polyclinic].
    Kozlitskiĭ AP
    Vestn Khir Im I I Grek; 1982 Sep; 129(9):120-3. PubMed ID: 7147583
    [No Abstract]   [Full Text] [Related]  

  • 53. [Use of vasculat in the treatment atherosclerosis obliterans of the extremities].
    Politowski M; Zelazny T
    Przegl Lek; 1965; 21(6):434-6. PubMed ID: 4379214
    [No Abstract]   [Full Text] [Related]  

  • 54. [Therapeutic management of arteriosclerosis obliterans of the extremities].
    Martorell F
    Angiologia; 1966; 18(4):155-61. PubMed ID: 5914613
    [No Abstract]   [Full Text] [Related]  

  • 55. [Medical therapy of obliterating arteriosclerosis of the lower extremities].
    MILANES B; CARRILLO RIERA P; PEREZ M
    Angiologia; 1958; 10(3):142-50. PubMed ID: 13533934
    [No Abstract]   [Full Text] [Related]  

  • 56. [An analysis of the complications developing during the performance of plasmapheresis in patients with the late stages of arteriosclerosis obliterans of the vessels of the lower extremities].
    Belotserkovskiĭ MV; Dubikaĭtis AIu; Timofeeva MB; Strashnov VI; Bogomolov MS; Tokarevich KK; Shlomin VV
    Vestn Khir Im I I Grek; 1994; 152(1-2):105-7. PubMed ID: 7701722
    [No Abstract]   [Full Text] [Related]  

  • 57. [Vasaprostan in everyday practice of vascular surgery department].
    Kokhan EP; Pinchuk OV; Batrashov VA
    Angiol Sosud Khir; 2003; 9(4):127-30. PubMed ID: 14657924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical experience with prostaglandin E1 in the treatment of arteriosclerosis obliterans. A preliminary report.
    Ambrus JL; Taheri P; Killion D; Donaldson G
    J Med; 1983; 14(1):1-15. PubMed ID: 6577118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of buflomedil in the treatment of obliterative arteriopathies of the lower extremities. Clinical and functional study].
    Cospite M; Ferrara F; Milio G; Meli F
    Clin Ter; 1984 Apr; 109(2):127-35. PubMed ID: 6234122
    [No Abstract]   [Full Text] [Related]  

  • 60. [Blood viscosity in chronic peripheral obliterating arteriopathy].
    Trabattoni P; Losapio GM; Bianchi T
    Arch De Vecchi Anat Patol; 1965 Nov; 46(1):99-106. PubMed ID: 5870494
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.